Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Dantes · SciRah

Researcher profile · Semantic Scholar

M. Dantes

Share profile

M. Dantes — researcher profile on SciRah

h-index: 9
Works: 46
Citations: 236

Most-cited papers

Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
L. Käsmann, C. Eze, J. Taugner, O. Roengvoraphoj +5 more
2020Radiation Oncology37 citations Open access
Semantic Scholar
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
F. Manapov, L. Käsmann, O. Roengvoraphoj, M. Dantes +3 more
2018Lung Cancer31 citations Open access
Semantic Scholar
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
L. Käsmann, J. Taugner, C. Eze, O. Roengvoraphoj +7 more
2019Anticancer Research29 citations Open access
Semantic Scholar
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer
O. Roengvoraphoj, C. Wijaya, C. Eze, Ming-Lun Li +6 more
2017Strahlentherapie und Onkologie (Print)25 citations
Semantic Scholar
Pneumonitis in Irradiated Lungs After Nivolumab: A Brief Communication and Review of the Literature.
F. Manapov, O. Roengvoraphoj, M. Dantes, S. Marschner +2 more
2017Journal of immunotherapy25 citations Open access
Semantic Scholar
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours-a German radiation oncology survey.
L. Käsmann, C. Eze, M. Dantes, O. Roengvoraphoj +3 more
2019European Journal of Cancer17 citations
Semantic Scholar
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy.
J. Taugner, L. Käsmann, C. Eze, M. Dantes +7 more
2019Translational Lung Cancer Research14 citations Open access
Semantic Scholar
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience
O. Roengvoraphoj, C. Eze, C. Wijaya, M. Dantes +6 more
2018European Journal of Nuclear Medicine and Molecular Imaging14 citations
Semantic Scholar
Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature
C. Eze, N. Hegemann, O. Roengvoraphoj, M. Dantes +1 more
2017Frontiers in Oncology9 citations Open access
Semantic Scholar
Relevance of tumor boards for the inclusion of patients in oncological clinical trials
H. Dapper, M. Dantes, P. Herschbach, H. Algül +1 more
2023Journal of Cancer Research and Clinical Oncology8 citations Open access
Semantic Scholar
Features of chronic hepatitis in alcoholics. A survey in Milan.
L. Adelasco, A. Monarca, M. Dantes, M. Moioli +5 more
2008Liver7 citations
Semantic Scholar
Feasibility of hypofractionated radiotherapy in inoperable node-positive NSCLC patients with poor prognostic factors and limited pulmonary reserve: a prospective observational study
C. Eze, J. Taugner, N. Schmidt-Hegemann, L. Käsmann +7 more
2021Acta oncologica6 citations Open access
Semantic Scholar
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy
L. Käsmann, Reem Abdo, C. Eze, M. Dantes +6 more
2020Lung4 citations
Semantic Scholar
Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey
C. Eze, O. Roengvoraphoj, M. Dantes, Reem Abdo +4 more
2018Anticancer Research3 citations Open access
Semantic Scholar
Onco-PDO test utilizing patient-derived organoids (PDOs) and next-generation precision oncology in breast cancer.
Z. Dantes, Linda Huang, J. Slawska, A. Manjunath +13 more
2023Journal of Clinical Oncology2 citations Open access
Semantic Scholar
Pattern of first-site failure and salvage treatment in patients with inoperable stage III non-small cell lung cancer after chemoradiotherapy.
C. Eze, J. Taugner, L. Käsmann, O. Roengvoraphoj +4 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?
C. Eze, O. Roengvoraphoj, N. Schmidt-Hegemann, L. Käsmann +2 more
2018Clinical Respiratory Journal1 citations
Semantic Scholar
Immune Checkpoint Inhibition Combined With Intracranial Stereotactic Radiation Therapy in Non-Small Cell Lung Cancer: Is There an Increasing Rate of Radionecrosis or Not? In Regards to Schapira et al, Huppeling et al and Colaco et al.
L. Käsmann, M. Dantes, O. Roengvoraphoj, C. Eze +1 more
2018International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
18FDG-PET/CT for the Visualization of Inflammatory Component of Radiation-Induced Lung Injury After Stereotactic Radiotherapy.
O. Roengvoraphoj, Montserrat Pazos-Escudero, C. Eze, M. Dantes +1 more
2017Clinical Nuclear Medicine1 citations
Semantic Scholar
Influence of diabetic treatment regimens on vitamin D metabolism in elderly patients.
P. D. Raconesi, M. T. Taddei, G. Ragonesi, M. Dantes +1 more
1996Archives of gerontology and geriatrics (Print)1 citations
Semantic Scholar
233P Breast cancer organoids mimic disease heterogeneity, allow high-throughput drug screening and show correlation with clinical response
Z. Dantes, A. Manjunath, L. Ferreira, J. Slawska +13 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
PO-1031: Initial report on feasibility of Hypo-IGRT in stage IIB-III NSCLC pts with poor PS & lung function
C. Eze, J. Taugner, N. Schmidt-Hegemann, O. Roengvoraphoj +5 more
20200 citations
Semantic Scholar
SURG-34. MULTIDISCIPLINARY MANAGEMENT OF A PATIENT WITH OPTIC PATHWAY-HYPOTHALAMIC LANGERHANS CELL HISTIOCYTOSIS: A CASE REPORT
John Emmanuel Custodio, Kevin Paul Ferraris, Joseph Erroll V Navarro, Kenny S. Seng +2 more
20200 citations Open access
Semantic Scholar
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy
L. Käsmann, C. Eze, J. Taugner, O. Roengvoraphoj +5 more
2020Radiation Oncology0 citations Open access
Semantic Scholar
Adjuvant radiotherapy additionally to chemotherapy in resected node‐positive small cell lung cancer: A role assessment without randomized evidence
M. Dantes, L. Käsmann, O. Roengvoraphoj, F. Manapov +1 more
2020Clinical Respiratory Journal0 citations
Semantic Scholar
The role of patient performance status and its changes before and after completion of multimodal treatment for inoperable stage III NSCLC.
L. Käsmann, J. Taugner, C. Eze, O. Roengvoraphoj +6 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC)
L. Käsmann, R. Abdo, C. Eze, M. Dantes +7 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy
L. Käsmann, J. Taugner, C. Eze, M. Dantes +7 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
External validation of a survival score for limited stage small cell lung cancer treated with chemoradiotherapy.
L. Käsmann, R. Abdo, J. Taugner, C. Eze +4 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy
Julian Taugner, L. Käsmann, C. Eze, M. Dantes +7 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
Heterogeneity score in inoperable stage III non-small cell lung cancer patients treated with definitive chemoradiotherapy: A single centre analysis.
J. Taugner, L. Käsmann, C. Eze, M. Dantes +6 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy
K. Gennen, L. Käsmann, C. Eze, M. Dantes +11 more
2019Radiotherapy and Oncology0 citations Open access
Semantic Scholar
Prognostic value of CD8-positive tumor stroma-infiltrating lymphocytes and PD-L1 positive tumor cells at initial biopsy in patients with locally advanced NSCLC treated with chemoradiotherapy.
K. Gennen, L. Käsmann, C. Eze, M. Dantes +8 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
P2.17-18 A Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer
J. Taugner, O. Roengvoraphoj, L. Käsmann, O. Petruknov +6 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP-1489: Outcome after neoadjuvant chemoradiation in elderly patients (≥ 70 years) with rectal cancer
F. Roeder, M. Dantes, R. Isleiwa, S. Gerum +2 more
20180 citations Open access
Semantic Scholar
114P Evaluation of pulmonary function parameters after moderate hypofractionated image-guided thoracic irradiation in locally advanced node-positive non-small cell lung cancer patients with very limited lung function
F. Manapov, O. Roengvoraphoj, J. Taugner, M. Dantes +3 more
20180 citations Open access
Semantic Scholar
86P Prophylactic cranial irradiation in SCLC: A survey of German radiation oncology institutions on recommendations for brain imaging
C. Eze, O. Roengvoraphoj, M. Dantes, R. Abdo +3 more
20180 citations Open access
Semantic Scholar
84P Patterns of care for patients with small cell lung cancer: A survey of German radiation oncology institutions on recommendations for prophylactic cranial irradiation
C. Eze, O. Roengvoraphoj, M. Dantes, R. Abdo +3 more
20180 citations Open access
Semantic Scholar
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer
O. Roengvoraphoj, C. Wijaya, C. Eze, Ming-Lun Li +6 more
2018Strahlentherapie und Onkologie (Print)0 citations Open access
Semantic Scholar
Mediastinal lymph node clearance and anti-PD-1 induction in resected NSCLC.
Farkhad Manapov, C. Eze, L. Käsmann, M. Dantes +1 more
2018Annals of Oncology0 citations Open access
Semantic Scholar
117P Feasibility of moderate hypofractionated image-guided thoracic irradiation for locally advanced node-positive non-small cell lung cancer patients with very limited lung function
F. Manapov, O. Roengvoraphoj, J. Taugner, M. Dantes +3 more
20180 citations Open access
Semantic Scholar
P3.01-25 Feasibility of Moderate Hypofractionated Thoracic Irradiation for Non-Small Cell Lung Cancer Patients with Very Limited Lung Function
F. Manapov, O. Roengvoraphoj, J. Taugner, M. Dantes +5 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
C. Eze, O. Roengvoraphoj, M. Dantes, F. Manapov
2017The Lancet Oncology0 citations Open access
Semantic Scholar
73PDPrognostic value of pre- to post-treatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a patient cohort with inoperable locally-advanced NSCLC treated with definitive chemoradiotherapy
O. Roengvoraphoj, C. Eze, W. Fendler, M. Dantes +2 more
20170 citations Open access
Semantic Scholar
Outcome after neoadjuvant chemoradiation in elderly patients (>= 70 years) with rectal cancer
M. Dantes, R. Isleiwa, S. Gerum, Alexandria Jensen +2 more
20170 citations
Semantic Scholar
PD Video-Assisted Thoracic Surgery ( VATS ) lobectomy for non-small cell lung cancer after induction chemotherapy : A propensity score-matched analysis on behalf of the Italian VATS group
C. Eze, W. Fendler, M. Dantes, C. Belka +9 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Eze×37
Invite
C. Eze — researcher profile on SciRah
F. Manapov×37
Invite
F. Manapov — researcher profile on SciRah
O. Roengvoraphoj×36
Invite
O. Roengvoraphoj — researcher profile on SciRah
C. Belka×28
Invite
C. Belka — researcher profile on SciRah

×21

Invite

J. Taugner — researcher profile on SciRah

L. Käsmann×13

Invite

L. Käsmann — researcher profile on SciRah

L. Käsmann×12

Invite

L. Käsmann — researcher profile on SciRah

N. Schmidt-Hegemann×11

Invite

N. Schmidt-Hegemann — researcher profile on SciRah

Invite

K. Gennen — researcher profile on SciRah

Invite

A. Tufman — researcher profile on SciRah

Invite

M. Karin — researcher profile on SciRah

Invite

C. Wijaya — researcher profile on SciRah